MetLife (MET) Form 144 filing details planned 30-share sale

MetLife (MET) has a Form 144 notice covering a planned sale of common stock for the account of a reporting holder.

Rhea-AI Filing Summary

MetLife (MET) has a Form 144 notice covering a planned sale of common stock for the account of a reporting holder. The filing states that the holder intends to sell 30 shares of common stock through Barclays on the NYSE on or about 11/20/2025, with an aggregate market value of 2242.8. These 30 shares were acquired on 10/11/2021 via a purchase from Citigroup Global Markets, paid in cash on 10/13/2021.

The notice also lists other recent sales of the issuer’s common stock over the past three months by MetLife-related accounts, including 333 shares sold by MetLife 401k Plan Trust-Large Cap Equity Index on 10/01/2025 for gross proceeds of 27282.69 and 196 shares sold by MetLife 401k Plan Russell 1000 Value on 10/29/2025 for 15350.72. The signer represents that they are not aware of undisclosed material adverse information about the issuer.

FAQ

What does the MET Form 144 filing disclose about upcoming stock sales?

The Form 144 for MetLife (MET) discloses that a reporting holder intends to sell 30 shares of MET common stock through Barclays on the NYSE on or about 11/20/2025, with an aggregate market value of 2242.8.

How many MET shares are being reported for sale in this Form 144?

The filing reports a planned sale of 30 shares of MET common stock, with an aggregate market value of 2242.8, to be sold through Barclays on the NYSE.

When and how were the MET shares in this Form 144 acquired?

The 30 shares of MET common stock were acquired on 10/11/2021 via a purchase from Citigroup Global Markets, with payment made in cash on 10/13/2021.

Which broker and exchange are involved in the MET Form 144 sale?

The planned sale in the MET Form 144 will be executed through Barclays, located at 745 Seventh Ave, New York, NY 10019, on the NYSE securities exchange.

What recent MET stock sales over the past 3 months are listed in the filing?

The filing lists several recent sales, including 64 shares by Separate Account II on 09/19/2025 for 5066.24, 269 shares by MetLife 401k Plan Trust-Large Cap Equity Index on 09/19/2025 for 21294.04, and 333 shares by the same plan on 10/01/2025 for 27282.69.

What representation does the seller make in the MET Form 144 notice?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/20/2025 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000728240
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MetLife, Inc.
SEC File Number	001-15787
Address of Issuer	200 Park Avenue New York NEW YORK 10016
Phone	212-578-2211
Name of Person for Whose Account the Securities are To Be Sold	Separate Account 149- MetropolitanTower Life Ins Co
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	30	2242.8	30	11/20/2025	N Y S E

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/11/2021	Purchase	Citigroup Global Markets			30	10/13/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	64	5066.24
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	269	21294.04
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	221	17494.36
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	09/19/2025	17	1345.72
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	10/01/2025	333	27282.69
MetLife 401k Plan Russell 1000 Value 1 Metlife Way Whippany NJ 07981	Common Stock	10/29/2025	196	15350.72

144: Remarks and Signature

Remarks
Date of Notice	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mirsad Usejnoski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)